Posted 26 January, 2023
GENELUX CORP IPO completed
IPO completed detected for ticker Nasdaq:GNLX in a 424B4 filed on 26 January, 2023.
This is an initial public offering of shares of common stock of Genelux Corporation.
Don't know how to trade IPO completion? Read Initial Public Offerings.
Overview of GENELUX CORP
Health Care/Life Sciences • Biotechnology
Genelux Corp. manufactures and markets drugs and virus strains solutions. It provides drug research, development, and clinical trial services for the healthcare industry. The company was founded by Aladar Szalay in 2001 and is headquartered in Westlake Village, CA.Market Cap
$184M
View Company Details
$184M
Interested in special situations?
Join Tickerverse
- customize event filters
- create watchlists, bookmarks
- get email notifications for the latest special situations
- browse and analyze public companies, executives and SEC filings
Tickerverse is a great way to find investment opportunities in corporate actions.
By signing up you agree to our Terms of Service and Privacy Policy.